Clinical trial
SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder
NCT00479687 · Bioventus LLC, Industry · Completed
Key facts
| NCT number | NCT00479687 |
|---|---|
| Title | SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder |
| Official title | A Multi-center, Randomized, Double-blind, Placebo Controlled Trial of SUPARTZ (Sodium Hyaluronate) for the Treatment of Chronic Shoulder Pain |
| Lead sponsor | Bioventus LLC, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoarthritis of the Shoulder |
| Intervention type | Device |
| Interventions | SUPARTZ®, Phosphate Buffered Saline |
| Enrollment | 300 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | May 28, 2007 |
| Last update posted | Apr 27, 2021 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: